Foghorn Therapeutics (NASDAQ:FHTX – Get Free Report)‘s stock had its “outperform” rating reissued by equities researchers at Wedbush in a note issued to investors on Thursday,RTT News reports. They currently have a $10.00 price target on the stock. Wedbush’s price target would indicate a potential upside of 149.07% from the stock’s current price. Several other [...]
Foghorn Therapeutics’ (FHTX) Outperform Rating Reiterated at Wedbush
